Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Glucokinase

Glucokinase is an enzyme that facilitates phosphorylation of glucose to glucose-6-phosphate. Glucokinase occurs in cells in the liver and pancreas of humans and most other vertebrates. In each of these organs it plays an important role in the regulation of carbohydrate metabolism by acting as a glucose sensor, triggering shifts in metabolism or cell function in response to rising or falling levels of glucose, such as occur after a meal or when fasting. Mutations of the gene for this enzyme can cause unusual forms of diabetes or hypoglycemia.Glucokinase (GK) is a hexokinase isozyme, related homologously to at least three other hexokinases. All of the hexokinases can mediate phosphorylation of glucose to glucose-6-phosphate (G6P), which is the first step of both glycogen synthesis and glycolysis.

AP-III-a4
T67591177827-73-4
AP-III-a4 (ENOblock) (ENOblock) is the first nonsubstrate analogue inhibitor of enolase with IC50 of 0.576 μM.
  • $47
In Stock
Size
QTY
TargetMol | Inhibitor Hot
POMHEX
T364912004714-34-3
Pomhex, a cell-permeable potent enolase inhibitor with anticancer activity, is used in the study of cancer lethality.Pomhex, a racemic mixture, is a potent and selective ENO2 inhibitor.Pomhex is inhibitory to the glycolytic process, and shows anticancer activity at low concentrations in an ENO1-deficient tumor model.Pomhex, a cell-permeable potent enolase inhibitor with anticancer activity, is a potent and selective ENO2 inhibitor.
  • $148
In Stock
Size
QTY
3PO
T2222318550-98-6
3PO is a small-molecule inhibitor of PFKFB3 (IC50: 22.9 μM), inhibiting the proliferation of several human malignant hematopoietic and adenocarcinoma cell lines (IC50: 1.4-24 μM). It suppresses glucose uptake, and decreases the intracellular concentration
  • $52
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Kaempferitrin
T3386482-38-2
Kaempferitrin (Lespenephryl) has antidepressant-like effect related to the serotonergic system, principally 5-HT1A. Kaempferitrin exerts cytotoxic and antitumor effects against HeLa cells. Kaempferitrin stimulates glucose-metabolizing enzymes, promotes glucose homeostasis. Kaempferitrin exerts immunostimulatory effects on immune responses mediated by splenocytes, macrophages, PBMC and NK cells. Kaempferitrin induces cytotoxic effects to include: cell cycle arrest in G1 phase and apoptosis via the intrinsic pathway in a caspase-dependent pathway.
  • $43
In Stock
Size
QTY
PFK-158
T31051462249-75-7
PFK-158 is an effective and specific inhibitor PFKFB3.
  • $30
In Stock
Size
QTY
TargetMol | Inhibitor Sale
TargetMol | Citations Cited
MitoPQ
T334121821370-28-8
MitoPQ (MitoParaquat) is a mitochondria-targeted small molecule compound that selectively enhances mitochondrial superoxide and hydrogen peroxide levels and inhibits insulin-stimulated glucose uptake and translocation of glucose transport protein 4 (GLUT4) to the plasma membrane in adipocytes and myotubes.MitoPQ can be used to MitoPQ can be used to study mitochondrial oxidative stress and regulated GLUT4 transporter.
  • $41
In Stock
Size
QTY
KAN0438757
T117411451255-59-6
KAN0438757 is a selective and potent inhibitor of the metabolic kinase [PFKFB3] with an IC50 of 0.19 μM.
  • $103
In Stock
Size
QTY
ML251
T643201486482-16-9
ML251 is a potent novel nanomolar inhibitor of T. brucei and T. cruzi phosphofructokinase[1]. ML251 inhibits T. brucei PFK (IC50=0.37 μM) and T. cruzi PFK (IC50=0.13 μM). ML251 can be used for the research of parasite[1].
  • $135
In Stock
Size
QTY
Palmitelaidic Acid
T1950010030-73-6
Palmitelaidic Acid (trans-Palmitoleic acid) is one of the most abundant fatty acids in serum and tissue.
  • $80
In Stock
Size
QTY
AZD-1656
T26712919783-22-5
AZD-1656 is a glucokinase activator (GKA) that can cause dose-limiting hypoglycemia in normal animals used in embryofetal development studies and type 2 diabetes.
  • $84
In Stock
Size
QTY
PFK-015
T24554382-63-2
PFK-015 (PFK15) is an effective inhibitor of PFKFB3 (IC50: 110 nM) and inhibits PFKFB3 activity in Y cells (IC50: 20 nM).
  • $52
In Stock
Size
QTY
TargetMol | Citations Cited
Dorzagliatin
T151591191995-00-2
Dorzagliatin (HMS5552) is a dual-acting glucokinase (GK) activator. It also improves glycaemic control and pancreatic β-cell function in type 2 diabetes.
  • $34
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Genz-123346 free base
T4049491833-30-8
Genz 123346 is an inhibitor of GL1 synthase that blocks the conversion of ceramide to GL1.
  • $43
In Stock
Size
QTY
TargetMol | Inhibitor Sale
WAY-640509
T60048851185-20-1
WAY-640509 is a glucocerebrosidase inhibitor.
  • $117
In Stock
Size
QTY
AMG-3969
TQ00551361224-53-4
AMG-3969 is an effective glucokinase-glucokinase regulatory protein interaction (GK-GKRP) disruptor (IC50: 4 nM).
  • $123
In Stock
Size
QTY
ML198
T89861380716-06-2
ML198 is a novel activator and non-inhibitory chaperone of glucocerebrosidase. ML198 serves as a starting point to develop a novel approach towards small molecule treatment for patients suffering from Gaucher disease.
  • $41
In Stock
Size
QTY
TargetMol | Inhibitor Sale
5MPN
T4056547208-82-2
5MPN is an orally active and selective inhibitor of 6-phosphofructokinase-2-kinase (PFKFB4) that competitively inhibits the F6P binding site and inhibits the proliferation of myeloma cells, and can be used in the study of myeloproliferative neoplasms.
    Inquiry
    YZ9
    T235526093-71-6
    Y29 is a potent PFKFB3 inhibitor with an IC50 of 0.183 µM, acting as a competitive inhibitor against Fru-6-P with a Ki of 0.094 µM[1].
    • $50
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
    PF-04937319
    T164791245603-92-2In house
    PF-04937319 is an activator of glucokinase (EC50 =154.4  μM). PF-04937319 maintains glucose-lowering efficacy while mitigating the risk of hypoglycemia observed with many other glucokinase activators. PF-04937319 can be used in research on the treatment of type 2 diabetes mellitus.
    • $38
    In Stock
    Size
    QTY
    SF2312
    T28764107729-45-3
    SF2312 is a natural phosphonate antibiotic produced by Actinobacillus microsporus and is a potent inhibitor of the glycolytic enzyme enolase.SF2312 has antimicrobial activity and inhibits bacterial growth against both Gram-negative and Gram-negative bacteria. SF2312 inhibits human recombinant ENO1 and ENO2.
    • $115
    In Stock
    Size
    QTY
    Oxfendazole
    T071453716-50-0
    Oxfendazole (RS-8858), a broad spectrum benzimidazole anthelmintic, protects livestock against roundworm, strongyles and pinworms.
    • $31
    In Stock
    Size
    QTY
    AM-2394
    T33121442684-77-6
    AM-2394 is an effective and specific Glucokinase agonist (GKA, EC50: 60 nM), which catalyzes the phosphorylation of glucose to glucose-6-phosphate. AM-2394(AM2394) increases the affinity of GK for glucose by approximately 10-fold, exhibits moderate clearance and good oral bioavailability in multiple animal models, and lowers glucose excursion following an oral glucose tolerance test in an ob ob mouse model of diabetes.
    • $38
    In Stock
    Size
    QTY
    MK-0941 free base
    T12056752240-01-0
    MK-0941 free base is an orally active glucokinase activator with potent glucose-lowering activity, making it a potential therapeutic agent for type 2 diabetes.
    • $79
    In Stock
    Size
    QTY
    Globalagliatin
    T31041234703-40-2In house
    Globalagliatin (LY2608204) has been used in trials studying the treatment of Diabetes Mellitus, Type 2.
    • $32
    In Stock
    Size
    QTY
    ML266
    T89901462267-08-8
    ML266, a glucocerebrosidase (GCase) chaperone with an IC50 of 2.5 µM, facilitates the transport of the mutant protein to the lysosome, thereby restoring GCase activity without inhibiting the enzyme's function. This compound shows promise for Gaucher disease research.
    • $48
    In Stock
    Size
    QTY
    AZ PFKFB3 26
    T143651704740-52-2In house
    AZ PFKFB3 26 is an effective and selective PFKFB3 inhibitor with an IC50 of 23 nM. The IC50s for PFKFB1 and PFKFB2 are 2.06 and 0.384 μM, respectively.
    • $30
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
    (E)-3PO
    T326013309-08-5
    (E)-3PO is a PFKFB3 (6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase) inhibitor.
    • $30
    In Stock
    Size
    QTY
    TargetMol | Citations Cited
    ARRY-403
    T301421138669-65-4In house
    ARRY-403 is a novel glucokinase activator that reduces fasting and postprandial blood glucose in patients with type 2 diabetes.
    • $988
    In Stock
    Size
    QTY
    AMG-1694
    T142121361217-07-3In house
    AMG-1694, a potent disruptor of the glucokinase–glucokinase regulatory protein (GK-GKRP) complex, operates by promoting the dissociation of this complex, thereby indirectly enhancing GK enzymatic activity with an IC50 of 7 nM. It effectively normalizes blood glucose levels in various rodent diabetes models [1] and lowers blood glucose specifically in diabetic animals without affecting normoglycemic ones. Additionally, AMG-1694 reverses the GKRP-induced inhibition of GK activity and facilitates GK translocation.
    • $380
    In Stock
    Size
    QTY
    (1S,2R)-Globalagliatin
    T3104L2514278-46-5In house
    (1S,2R)-Globalagliatin is a highly potent glucokinase (GK) activator for the study of type 2 diabetes.
    • $45
    In Stock
    Size
    QTY
    PFKFB3-IN-2
    T67874794552-84-4
    PFKFB3-IN-2 is an inhibitor of 6-phosphofructo-2-kinase fructose-2,6-bisphosphatase 3 (PFKFB3). Anti-sense treatment against PFKFB3 has demonstrated a reduction in tumor growth rate in vivo.
    • $45
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
    WAY-297848
    T77784404360-27-6
    WAY-297848 is a novel glucokinase activator for the prevention or treatment of hyperglycemia, diabetes mellitus, obesity, dyslipidemia, and metabolic syndrome.
    • $30
    In Stock
    Size
    QTY
    KDM4-IN-2
    T117492369607-62-3In house
    KDM4-IN-2 is a potent and selective KDM4/KDM5 dual inhibitor with Kis of 4 and 7 nM for KDM4A and KDM5B, respectively.
    • $1,520
    8-10 weeks
    Size
    QTY
    PF-04991532
    T164801215197-37-7
    PF-04991532 is an effective, hepatoselective glucokinase activator. It has EC50s of 80 and 100 nM in human and rat, respectively.
    • $78
    5 days
    Size
    QTY
    Tangshenoside I
    TN5094117278-74-7
    Tangshenoside I might be a potential bioactive marker related to the hematopoietic and immunologic functions of Codonopsis Radix, which could be recommended as the index compound. It has α-glucosidase inhibition activity.
      Inquiry
      ADP-specific glucokinase
      T89882173585-07-4
      ADP-specific glucokinase, expressed in thermophilic archaea, is an ADP-specific enzyme that catalyzes the conversion of glucose to glucose-6-phosphate, thereby facilitating glycolysis. This enzyme can activate T cells and enhance the phagocytic activity of macrophages. It is used in research related to metabolic disorders, neurological diseases, and tumors.
      • Inquiry Price
      Size
      QTY
      Tuberosin
      TN519241347-45-9
      Tuberosin shows anti-inflammatory and antioxidant activities.It demonstrated a significantly potent inhibition on yeast α-glucosidase in a dose dependent manner.
      • $480
      Backorder
      Size
      QTY
      Pinoresinol diacetate
      TN479332971-25-8
      Pinoresinol diacetate inhibits the enzyme α-glucosidase in vitro and may therefore act as a hypoglycemic agent.
      • $460
      Backorder
      Size
      QTY
      Cefetrizole
      T1075165307-12-2
      Ceftezole, an α-glucosidase inhibitor [IC50: 2.1 μM; Ki: 0.578 μM].
      • $1,520
      6-8 weeks
      Size
      QTY
      Guajadial
      TN4174959860-49-2
      Guajadial shows α-glucosidase inhibitory activities significantly and its activity was better than that of Acarbose.Guajadial may act as Selective Estrogen Receptors Modulators (SERMs), therefore holding significant potential for anticancer therapy, it ex
      • $820
      Backorder
      Size
      QTY
      Tachioside
      TN5090109194-60-7
      Tachioside has antiobesity, antioxidant and α-glucosidase inhibitory activities, it decreases lipid content in 3T3-L1 adipocytes by inhibiting lipogenesis, shows antiobesity activities. Tachioside can inhibit nitric oxide production in lipopolysaccharides-stimulated RAW 264.7 cells with IC50 value of 12.14 μM.
      • $210
      Backorder
      Size
      QTY
      Cyclomusalenone
      TN374530452-60-9
      Cyclomusalenone is a potent α-glucosidase inhibitor.
      • $460
      Backorder
      Size
      QTY